4-O-Methylhonokiol: A Lesser-Known Neolignan from Magnolia Species with Diverse and Promising Pharmacological Properties

    Qian Wei, Chiang Chan
    Image of study
    TLDR 4-O-Methylhonokiol from Magnolia shows promise for hair growth, cancer, diabetes, and more, but needs better absorption.
    The review focused on 4-O-methylhonokiol (MH), a neolignan from Magnolia species, which exhibited diverse pharmacological properties, including promoting hair growth, anticancer, antidiabetes, anti-inflammatory, anxiolytic, and antiobesity effects. MH significantly increased hair growth in rat vibrissa follicles by 2.5 times compared to the control group. It also showed potential in treating diabetic nephropathy and cardiomyopathy in mice by reducing oxidative stress and improving lipid metabolism. Despite its promising profile, MH had poor oral absorption and high systemic clearance, indicating a need for analogs with improved metabolic stability. The review suggested that MH's effects could be enhanced when combined with other neolignans like honokiol and magnolol, warranting further investigation into its mechanisms and potential applications.
    Discuss this study in the Community →

    Research cited in this study

    2 / 2 results

    Related Community Posts Join

    6 / 1000+ results

      community (29M) a four month journey into confidenceland

      in Progress Pictures  54 upvotes 1 year ago
      A 30-year-old man shares his positive experience with hair loss treatment using finasteride, minoxidil, tretinoin, and ketoconazole shampoo over four months, noting significant hair regrowth and increased confidence. He plans to continue the regimen with occasional breaks and emphasizes the importance of critically evaluating information about treatment side effects.

      community Surprisingly thorough study on He-Shou-Wu/Fo Ti

      in Research/Science  14 upvotes 2 years ago
      He Shou Wu (Fo Ti) extract was found to prolong the hair growth phase, inhibit 5-alpha-reductase (like finasteride), reduce androgen receptors, and increase growth factors, potentially outperforming minoxidil in recovering hair follicle size after DHT exposure. Two compounds, emodin and TSG, are identified as responsible for these effects and warrant further investigation.

      community What Else Do I Try? 5 Months Topical Fin No Progress

      in Progress Pictures  4 upvotes 7 months ago
      The user has been using topical finasteride, Latanoprost, and other treatments for hair loss but hasn't seen progress and is considering increasing the finasteride dosage or switching to dutasteride. They cannot use minoxidil due to heart issues and are seeking advice on other options.

    Similar Research

    5 / 1000+ results